IRLAB to Present the Company at Redeye Neurology Seminar on October 12, 2022
[ad_1] GOTHENBURG, SWEDEN / ACCESSWIRE / October 11, 2022 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a clinical-stage biopharmaceutical company discovering and developing novel treatments for…